Highlights: Revenue INR 50,733 Mn Y-o-Y 18.2% Net Profit INR 1,738 Mn EBITDA INR 6,380 Mn Y-o-Y -9.8% EBITDA Margins 12.6% Y-o-Y -390 Bps Diluted EPS INR 2.74 PAT Margins 3.4% Y-o-Y 916 Bps Net Profit INR 1,738 Mn Revenue INR 96,618 Mn Y-o-Y 34.6% EBITDA INR 12,048 Mn Y-o-Y 26.5% EBITDA Margins 12.5% Y-o-Y -80 Bps Net Profit INR 3,016 Mn PAT Margins 3.1% Y-o-Y 843 Bps Diluted EPS INR 4.75 Robust growth across both India and European operations driven by strong volume recovery, sharp execution and price increases taken Operating performance impacted by steep increase in RM costs and constrained OEM demand (especially for PCR) due to chip shortage Continued strong operating performance in Europe helped strengthen the consolidated operating margins Result PDF